Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Monoclonal antibodies
Dec 14, 2017
Izana Bioscience Launches as New Clinical-Stage Translational Medicine Company Developing Namilumab in Ankylosing Spondylitis
Dec 13, 2017
Regeneron and Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
Dec 13, 2017
Regeneron Collaboration Programs Highlighted During Sanofi Analyst Day
Dec 13, 2017
MabVax Therapeutics Announces Completion of Enrollment and Dosing in Initial Cohort of MVT-1075 Radioimmunotherapy Phase 1 Trial for the Treatment of Pancreatic, Colon and Lung Cancers
Dec 12, 2017
GSK achieves approval for Nucala (mepolizumab) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) for adults in the US
Dec 12, 2017
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome
Dec 11, 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Dec 11, 2017
Regeneron Announces FDA Acceptance of sBLA Filing for 12-Week Dosing of EYLEA® (aflibercept) Injection for Patients with Wet AMD
Dec 11, 2017
Global Biosimilar Monoclonal Antibodies Market Revenue CAGR to Exceed 35.7% - Marketresearch.biz
Dec 11, 2017
Kyowa Hakko Kirin Announces Results of Phase 3 Clinical Study of Mogamulizumab (KW-0761) in Patients with Cutaneous T-cell Lymphoma at the American Society of Hematology 2017
Dec 10, 2017
Targeted Therapies Show Promise for Improving Outcomes Across a Spectrum of Hematologic Malignancies
Dec 07, 2017
With Ocrevus Uptake in Primary Progressive Multiple Sclerosis a Relative Lock, Genentech and US Neurologists are Increasingly Focused on Ocrevus Positioning in Relapsing Forms of Multiple Sclerosis
Dec 07, 2017
Non-antibody Protein Scaffolds Drugs and Diagnostics Market, 2030 - 25+ Unique Non-antibody Protein Scaffolds Have Been Developed for the Generation of Different Product Candidates
Dec 05, 2017
Xencor Receives Milestone Payment from Amgen
Dec 04, 2017
Risankizumab Meets All Primary Endpoints Reporting Positive Results in Fourth Pivotal Phase 3 Psoriasis Study
Dec 04, 2017
Risankizumab Meets All Primary Endpoints Reporting Positive Results in Fourth Pivotal Phase 3 Psoriasis Study
Dec 04, 2017
Morphotek Announces Initiation Of Phase 1 Study Of Next-Generation Farletuzumab Antibody-Drug Conjugate MORAb-202 In Solid Tumors With Folate Receptor Alpha Expression
Dec 01, 2017
Lilly's Taltz® (ixekizumab) Receives U.S. FDA Approval for the Treatment of Active Psoriatic Arthritis
Nov 29, 2017
Aimovig(TM) (erenumab) Phase 3 STRIVE Data Published In The New England Journal Of Medicine Demonstrate Significant, Sustained Efficacy In Migraine Prevention
Nov 29, 2017
Dermatologists' Six Month Projections Reveal Janssen's Tremfya Closing in on the IL-17 Inhibitors, Novartis' Cosentyx and Eli Lilly's Taltz, in Psoriasis
‹‹
Page 39
››
Latest News
Mar 29, 2024
Dawson-Forté Cashmere Shareholders Sell Majority Equity Stake to Tempus Partners
Mar 29, 2024
Terragia Secures $6M to Develop Cost-Competitive, Low-Carbon Biofuel Technology
Mar 29, 2024
Sila Moses Lake Manager Rosendo Alvarado to Speak at Big Bend Community College Building the Future Energy...
Mar 28, 2024
White (Natural) Hydrogen Research Report 2024 Featuring Industry Leaders - Helios, Natural Hydrogen Energy,...
Mar 28, 2024
Asia-Pacific Satellite and Spacecraft Subsystem Industry Research 2023-2033: New Space Business Scenarios, 3D...
Mar 28, 2024
Europe Power Supply Equipment Market for Water Electrolysis Industry Research 2023-2032: Lucrative Demand and...
Mar 28, 2024
NewMarket Corporation Schedules Conference Call and Webcast to Review First Quarter 2024 Financial Results
Mar 28, 2024
Details of “SusHi Tech Tokyo 2024” Showcase Program Announced
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events